BLLN · NASDAQ · STOCK
BillionToOne, Inc.
$97.89
52W $61.96 – $150.44
59/100
$4.50B
141.9
0.34
Is BLLN Bullish or Bearish?
Mixed.
Innellis AI committee rates BillionToOne, Inc. (BLLN) Watch with a composite score of 59/100
, based on 5 analysts with 40% agreement.
Last updated August 11, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +0.81 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -19.19 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Value Analyst remains cautious — p/e of 123.4 is expensive by classic value standards. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- Low leverage (debt-to-equity 0.14) -- balance sheet can absorb a shock — Risk
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- P/E of 123.4 is expensive by classic value standards — Value
- Price-to-book of 7.8x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical
- Bollinger bandwidth of 53.2% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 11, 2026
Overall Committee Score
59/100
Agreement
40%
Analysts
5
Conviction
Contested
Sector Rank
Top 54%
of 192 Healthcare peers
Value Analyst
bearish
40
/ 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− P/E of 123.4 is expensive by classic value standards
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Risk Analyst
neutral
58
/ 100 · Moderate confidence
Moderate risk -- no single red flag, but nothing that clearly de-risks the position either
+ Low leverage (debt-to-equity 0.14) -- balance sheet can absorb a shock
− Bollinger bandwidth of 53.2% signals elevated volatility
Macro Analyst
bullish
78
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
neutral
60
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Technical Analysis
RSI (14)
30.9
Neutral
MACD Histogram
-5.580
Bearish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
0.09
Inside Bands
Price vs Moving Averages
EMA 9
$113.34
Below
EMA 21
$120.00
Below
EMA 50
$115.19
Below
EMA 200
$101.72
Below
Fundamental Analysis
Valuation
33
Profitability
40
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio
141.9×
P/B Ratio
8.47×
PEG Ratio
0.02
Dividend Yield
0.00%
52W High
$150.44
52W Low
$61.96
Quality & Growth
ROE
155.3%
ROA
117.8%
Gross Margin
7126.7%
Operating Margin
1089.6%
Revenue Growth YoY
—
Debt / Equity
0.27
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 141.9 (rich relative to a 15-40x range); Price-to-book of 8.5x; PEG ratio of 0.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 1.6%; Return on assets of 1.2%; Net margin of 8.4%; Gross margin of 71.3%; Current ratio of 11.69 (healthy short-term liquidity); Debt-to-equity of 0.27; Free cash flow per share is positive (0.71); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full BLLN Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →